Delcath Systems (DCTH) Reports Q4 Loss of $0.23/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. FICO
8. CART
9. LLY
10. TSLA

Go back to Delcath Systems (DCTH) Reports Q4 Loss of $0.23/Share

Delcath Announces 2015 Fourth Quarter and Full Year Financial Results

March 21, 2016 8:01 AM EDT

NEW YORK, March 21, 2016 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and 12 months ended December 31, 2015.

Highlights for the fourth quarter of 2015 and recent weeks include:

Fourth quarter 2015 revenue increased 51% to $0.4 million and full year 2015 revenue of $1.7 million increased 63% compared with 2014; Initiation of patient enrollment in the global Phase III trial: FOCUS Clinical Trial for Patients with Hepatic... More